Suppr超能文献

非酒精性脂肪性肝病患者人类白细胞抗原等位基因多态性分析

Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease.

作者信息

Karrar Azza, Hariharan Siddharth, Fazel Yousef, Moosvi Ali, Houry Mohamad, Younoszai Zahra, Jeffers Thomas, Zheng Li, Munkhzul Otgonsuren, Hunt Sharon, Monge Fanny, Goodman Zachary, Younossi Zobair M

机构信息

Betty and Guy Beatty Center for Integrated Research, Inova Health System.

Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA.

出版信息

Medicine (Baltimore). 2019 Aug;98(32):e16704. doi: 10.1097/MD.0000000000016704.

Abstract

The human leukocyte antigen (HLA) genes may play a role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and its progressive form, non-alcoholic steatohepatitis (NASH). The aim of this study was to assess the association of HLA class I and II alleles with NASH and its histological features.Deoxyribonucleic acid (DNA) was extracted from 140 subjects (85 biopsy-proven NAFLD and 55 controls) and genotyped for HLA (-A, -B, -C, -DR1, -DR3, -DQ, and -DP). Liver biopsies were assessed for presence of NASH, degree of fibrosis and inflammation. Multivariate analysis was performed to assess associations between HLA genes and different histologic features of NAFLD.Our data for HLA class I showed that HLA-C4 was associated with lower risk for histologic NASH and HLA-C6 was protective against portal fibrosis. Conversely, HLA-B27 was associated with high-grade hepatic steatosis, while HLA-A31 was associated with increased risk for advanced fibrosis. Among HLA class II alleles, HLA-DQA101 was associated with lower risk for NASH while HLA-DRB103 was associated with increased risk for NASH.Our findings indicate that HLA class I and II gene polymorphism may be associated with susceptibility to NASH, fibrosis and other pathologic features and may be involved in the pathogenesis of NAFLD.

摘要

人类白细胞抗原(HLA)基因可能在非酒精性脂肪性肝病(NAFLD)及其进展型非酒精性脂肪性肝炎(NASH)的发病机制中发挥作用。本研究旨在评估HLA I类和II类等位基因与NASH及其组织学特征之间的关联。从140名受试者(85例经活检证实的NAFLD患者和55名对照)中提取脱氧核糖核酸(DNA),并对HLA(-A、-B、-C、-DR1、-DR3、-DQ和-DP)进行基因分型。对肝活检组织进行NASH的存在情况、纤维化程度和炎症程度评估。进行多变量分析以评估HLA基因与NAFLD不同组织学特征之间的关联。我们关于HLA I类的数据显示,HLA-C4与组织学NASH的较低风险相关,HLA-C6对门静脉纤维化具有保护作用。相反,HLA-B27与重度肝脂肪变性相关,而HLA-A31与晚期纤维化风险增加相关。在HLA II类等位基因中,HLA-DQA101与NASH的较低风险相关,而HLA-DRB103与NASH的风险增加相关。我们的研究结果表明,HLA I类和II类基因多态性可能与NASH、纤维化及其他病理特征的易感性相关,并可能参与NAFLD的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b9/6708789/35a49554058e/medi-98-e16704-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验